In the original publication [1], there was a mistake in Figure 2, as published. An image from group E was mistakenly placed in group C in Figure 2 due to an incorrect folder selection. This error was facilitated by the fact that the image selected for group C exhibited normal structures with no observable tissue changes, making it visually indistinguishable from the intended selection. The correct Figure 2 and it’s legend appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 2.
Effect of the alvespimycin, OLPN, and their combined therapy on the histological structure of the lung. Sections of CTRL (A), 17-DMAG (B), and OLPN (C), respectively, show normal lung architecture formed of thin-walled alveoli. Section of BLCN-treated rats (D) shows substantial inflammatory cellular infiltration (asterisk) and marked thickening of inter-alveolar septa (forked arrow) compared to CTRL, 17-DMAG, or OLPN rats. Lung sections from rats with pulmonary fibrosis treated with 17-DMAG (E), OLPN (F), and their combined therapy (G) reveal mild inflammatory cellular infiltration and alveolar septal thickening (forked arrows) as confirmed by the inflammation score (H). Significance is indicated by the pairwise comparisons. * p < 0.05 vs. BLCN; *** p < 0.001 vs. CTRL.
The authors wish to replace the ‘Author Contributions’ statement for this article [1] with the following version since the wrong version was uploaded due to oversight:
- Author Contributions: Conceptualization, S.S.; methodology, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D. and R.S.H.; software, S.S.; validation, O.A.M., M.A.A.-R. and S.S.; formal analysis, O.A.M. and S.S.; investigation, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D., R.S.H. and S.S.; resources, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D. and R.S.H.; software, S.S.; validation, O.A.M., M.A.A.-R. and S.S.; data curation, O.A.M., M.A.A.-R., L.A.S., A.A.F., A.A.J.A., A.A.H., E.A.E., H.S.E.-w. and A.S.D.; contributed to writing—original draft preparation, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D., R.S.H. and S.S.; writing—review and editing, O.A.M., M.A.A.-R., L.A.S., M.M.S.A., J.A., M.I.E.A., A.A.F., A.A.J.A., W.F.B., A.A.H., S.A.-G., E.A.E., H.S.E.-w., A.S.D., R.S.H. and S.S.; visualization, A.A.F., J.A., A.A.J.A., W.F.B. and A.A.H.; supervision, M.M.S.A., J.A., M.I.E.A., A.A.J.A., W.F.B., A.A.H., S.A.-G., A.S.D. and S.S.; project administration, O.A.M., A.S.D. and S.S.; funding acquisition, O.A.M. All authors have read and agreed to the published version of the manuscript.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Mohammed, O.A.; Abdel-Reheim, M.A.; Saleh, L.A.; Alamri, M.M.S.; Alfaifi, J.; Adam, M.I.E.; Farrag, A.A.; AlQahtani, A.A.J.; BinAfif, W.F.; Hashish, A.A.; et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).